Contract Development Services

Jun 06, 2018
By Pharmaceutical Technology Editors
Under the contract, AMRI will focus on the development and manufacture of APIs and drug product for Phase I clinical studies.
Jun 02, 2018
Pharmaceutical Technology
From separation systems to reactor technology, new tools are increasing the feasibility of continuous API production.
Jun 01, 2018
By Pharmaceutical Technology Editors
Cambrex invests $5 million in new laboratory expansion at its Karlskoga, Sweden facility.
Jun 01, 2018
By Pharmaceutical Technology Editors
Catalent’s GPEx technology was used to develop antibody for anti-methamphetamine clinical study.
Jun 01, 2018
By Pharmaceutical Technology Editors
Madison Dearborn Partners will acquire a majority ownership position in CDMO Alcami.
May 16, 2018
By Pharmaceutical Technology Editors
Valerius Biopharma will use Catalent’s GPEx technology to produce cell lines for biosimilar drugs.
Apr 24, 2018
By Pharmaceutical Technology Editors
Porton will use biocatalyst technologies from Codexis to accelerate API development for clients.
Apr 20, 2018
By Pharmaceutical Technology Editors
The contract renewal allows AMRI to continue to provide medicinal chemistry and ADME services for advancing drug discovery programs in neurotherapeutics.
Apr 06, 2018
By Pharmaceutical Technology Editors
Anthony Qu, PhD, vice president of Scientific Affairs at Halo Pharma, will give a presentation on fixed-dose combination products, drug products containing multiple active ingredients, as an effective approach for simplified dosing at CPhI North America on Wednesday, April 25, 2018 in Philadelphia, PA.
Apr 05, 2018
Pharmaceutical Technology's In the Lab eNewsletter
By Pharmaceutical Technology Editors
The contract development and manufacturing organization announced the addition of a new building complex that will house its headquarters in Bothell, WA.
native1_300x100
lorem ipsum